Exploring the Anti-Tumor Efficacy of Combination Therapy with Inhibitors Targeting the Insulin-Like Growth Factor (IGF) and PI3K/AKT/MTOR Signaling Pathways for Hepatocellular Carcinoma (HCC)

Annals of Oncology - Tập 23 - Trang xi16 - 2012
D.-L. Ou1,2, C. Hsu3,4, B.-S. Lee2,3, Y.-C. Chang2,3, Y.-C. Cheng5, A.-L. Cheng1,3,4
1Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan
2National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan
3Department of Oncology, National Taiwan University Hospital Taipei, Taiwan
4Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
5Graduate Institute of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 23

xi16

Thông tin tác giả